Performance of the ESC/ERS 4-strata risk stratification model for pulmonary arterial hypertension with missing variables

Eur Respir J. 2023 Nov 29;62(5):2301023. doi: 10.1183/13993003.01023-2023. Print 2023 Nov.


In patients with PAH, the ESC/ERS 4-strata risk model maintains some of its discriminative power when one of the three parameters (WHO-FC, 6MWD, and BNP/NT-proBNP) is missing, although with an increasing likelihood of overestimating risk

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Familial Primary Pulmonary Hypertension
  • Humans
  • Hypertension, Pulmonary*
  • Pulmonary Arterial Hypertension*
  • Risk Assessment